These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22088139)

  • 41. Reaction between drug substances and pharmaceutical excipients: formation of esters between cetirizine and polyols.
    Yu H; Cornett C; Larsen J; Hansen SH
    J Pharm Biomed Anal; 2010 Nov; 53(3):745-50. PubMed ID: 20627436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of reaction products between drug substances and excipients by HPLC-SPE-NMR: ester and amide formation between citric acid and 5-aminosalicylic acid.
    Larsen J; Staerk D; Cornett C; Hansen SH; Jaroszewski JW
    J Pharm Biomed Anal; 2009 Apr; 49(3):839-42. PubMed ID: 19185440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystalline solid dispersion-a strategy to slowdown salt disproportionation in solid state formulations during storage and wet granulation.
    Nie H; Xu W; Taylor LS; Marsac PJ; Byrn SR
    Int J Pharm; 2017 Jan; 517(1-2):203-215. PubMed ID: 27979765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preformulation investigation and challenges; salt formation, salt disproportionation and hepatic recirculation.
    Sigfridsson K; Nilsson L; Ahlqvist M; Andersson T; Granath AK
    Eur J Pharm Sci; 2017 Jun; 104():262-272. PubMed ID: 28366653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product.
    Liu C; Dong S; Xu XJ; Yin Y; Shriver Z; Capila I; Myette J; Venkataraman G
    J Pharm Biomed Anal; 2011 Jan; 54(1):27-36. PubMed ID: 20800406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
    Tiwari RN; Bonde CG
    J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
    Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
    Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Forced degradation of fentanyl: identification and analysis of impurities and degradants.
    Garg A; Solas DW; Takahashi LH; Cassella JV
    J Pharm Biomed Anal; 2010 Nov; 53(3):325-34. PubMed ID: 20462721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reaction between drug substances and pharmaceutical excipients: formation of citric acid esters and amides of carvedilol in the solid state.
    Larsen J; Cornett C; Jaroszewski JW; Hansen SH
    J Pharm Biomed Anal; 2009 Jan; 49(1):11-7. PubMed ID: 18996664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Major degradation product identified in several pharmaceutical formulations against the common cold.
    Marín A; Espada A; Vidal P; Barbas C
    Anal Chem; 2005 Jan; 77(2):471-7. PubMed ID: 15649042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-time endpoint monitoring and determination for a pharmaceutical salt formation process with in-line FT-IR spectroscopy.
    Lin Z; Zhou L; Mahajan A; Song S; Wang T; Ge Z; Ellison D
    J Pharm Biomed Anal; 2006 Apr; 41(1):99-104. PubMed ID: 16321495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
    Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.
    He Y; Orton E; Yang D
    J Pharm Sci; 2018 Jan; 107(1):419-425. PubMed ID: 29107790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability of gabexate mesilate products: Influence of the addition of mannitol.
    Sakurai M; Abe H; Okamura N; Inoue Y; Akiyoshi T; Matsuyama K; Uchida T; Otsuka M
    Biomed Mater Eng; 2010; 20(1):13-20. PubMed ID: 20448300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An Unexpected Degradation Pathway of a 1,2,4-Triazolo[4,3-a]pyridine Derivative: The Formation of 2 Cationic Pseudodimers of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Drug Candidate in a Stressed Capsule Formulation.
    Huang Y; Wang Q; Wu Y
    J Pharm Sci; 2018 Jun; 107(6):1633-1641. PubMed ID: 29458062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preformulation evaluation of a photosensitive surface active compound, explaining concentration dependent degradation.
    Sigfridsson K; Carlsson KE
    Eur J Pharm Sci; 2017 Nov; 109():650-656. PubMed ID: 28736127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of counterion on the chemical stability of crystalline salts of procaine.
    Guerrieri P; Jarring K; Taylor LS
    J Pharm Sci; 2010 Sep; 99(9):3719-30. PubMed ID: 19967781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
    Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
    J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.